Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

In contrast, higher serum levels of vitamin D, alanine transaminase, albumin, hemoglobin, TG, uric acid, blood glucose, and fasting insulin were associated with a lower incidence of sarcopenia.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Systematic review.

Systematic review

Uses explicit methods to identify, assess and summarise research on a defined question.

Meta-analysis reported · Blinding not applicable to this review · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Systematic review and meta-analysis of biomarkers of sarcopenia and sarcopenic obesity

Source: Article title.

Systematic review and meta-analysis of biomarkers of sarcopenia and sarcopenic obesity

Source: Article title.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Systematic review and meta-analysis of biomarkers of sarcopenia and sarcopenic obesity

Systematic review · Medicine · 2026

Original publication title

Systematic review and meta-analysis of biomarkers of sarcopenia and sarcopenic obesity

Yaxian Yang; Chunyu Wang; Ruiyuan Xu; Wang Xuan; Xiaoai Chen

Copyright © 2026 the Author(s). Published by Wolters Kluwer Health, LLC.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

Abstract: What objectives does the paper state?

Sarcopenia and sarcopenic obesity (SO) are geriatric syndromes characterized by reduced skeletal muscle mass and impaired muscle strength, whose specific biomarkers and underlying mechanisms remain unclear. This study aimed to conduct a meta-analysis and literature review on the associations between biomarkers and sarcopenia/SO by collecting relevant publications over the past 15 years. We intended to further identify the shared and differential biomarkers of these disorders, thereby revealing their distinct pathophysiological processes and providing a basis for precise diagnosis and targeted intervention.

Source: Objective:

Abstract: What methods does the paper describe?

A comprehensive literature search was performed in PubMed, Embase databases for all publications from December 2010 to December 2025. We included English articles describing the associations between serum biomarkers and sarcopenia/SO, including cross-sectional studies, prospective cohort studies, and retrospective case studies, with no restrictions on race, population, or sample size. Literature screening was conducted in accordance with predefined inclusion and exclusion criteria. Relevant study data were extracted, and the quality of included studies was assessed. The mean difference and 95% confidence interval were used to calculate the pooled effect size.

Source: Methods:

Abstract: Results

A total of 43 English articles investigating the associations between biomarkers and sarcopenia/SO were finally included. Compared with non-sarcopenic patients, sarcopenic patients had elevated serum levels of C-reactive protein (CRP), interleukins, tumor necrosis factor, cystatin C, blood urea nitrogen, and high-density lipoprotein cholesterol (HDL-C). In contrast, higher serum levels of vitamin D, alanine transaminase, albumin, hemoglobin, TG, uric acid, blood glucose, and fasting insulin were associated with a lower incidence of sarcopenia. No significant differences were observed in WBC count, platelet count, aspartate transaminase, alkaline phosphatase, bilirubin, total cholesterol (TC), creatinine, erythrocyte sedimentation rate, low-density lipoprotein cholesterol (LDL-C), or thyroid-stimulating hormone levels between sarcopenic and non-sarcopenic patients.

Compared with healthy individuals, SO patients had higher serum levels of CRP, LDL-C, TC, TG, WBC, creatinine, uric acid, fasting blood glucose, and fasting insulin, while higher levels of HDL-C and vitamin D were associated with a lower risk of SO. SO patients had lower TG levels than patients with simple obesity, with no significant differences in CRP, HDL-C, LDL-C, TC, vitamin D, blood glucose, or interleukin-6 levels between the 2 groups.

Source: Results:
Authors’ abstract

Objective:

Sarcopenia and sarcopenic obesity (SO) are geriatric syndromes characterized by reduced skeletal muscle mass and impaired muscle strength, whose specific biomarkers and underlying mechanisms remain unclear. This study aimed to conduct a meta-analysis and literature review on the associations between biomarkers and sarcopenia/SO by collecting relevant publications over the past 15 years. We intended to further identify the shared and differential biomarkers of these disorders, thereby revealing their distinct pathophysiological processes and providing a basis for precise diagnosis and targeted intervention.

Methods:

A comprehensive literature search was performed in PubMed, Embase databases for all publications from December 2010 to December 2025. We included English articles describing the associations between serum biomarkers and sarcopenia/SO, including cross-sectional studies, prospective cohort studies, and retrospective case studies, with no restrictions on race, population, or sample size. Literature screening was conducted in accordance with predefined inclusion and exclusion criteria. Relevant study data were extracted, and the quality of included studies was assessed. The mean difference and 95% confidence interval were used to calculate the pooled effect size.

Results:

A total of 43 English articles investigating the associations between biomarkers and sarcopenia/SO were finally included. Compared with non-sarcopenic patients, sarcopenic patients had elevated serum levels of C-reactive protein (CRP), interleukins, tumor necrosis factor, cystatin C, blood urea nitrogen, and high-density lipoprotein cholesterol (HDL-C). In contrast, higher serum levels of vitamin D, alanine transaminase, albumin, hemoglobin, TG, uric acid, blood glucose, and fasting insulin were associated with a lower incidence of sarcopenia. No significant differences were observed in WBC count, platelet count, aspartate transaminase, alkaline phosphatase, bilirubin, total cholesterol (TC), creatinine, erythrocyte sedimentation rate, low-density lipoprotein cholesterol (LDL-C), or thyroid-stimulating hormone levels between sarcopenic and non-sarcopenic patients.

Compared with healthy individuals, SO patients had higher serum levels of CRP, LDL-C, TC, TG, WBC, creatinine, uric acid, fasting blood glucose, and fasting insulin, while higher levels of HDL-C and vitamin D were associated with a lower risk of SO. SO patients had lower TG levels than patients with simple obesity, with no significant differences in CRP, HDL-C, LDL-C, TC, vitamin D, blood glucose, or interleukin-6 levels between the 2 groups.

Publication and source details

Original title: Systematic review and meta-analysis of biomarkers of sarcopenia and sarcopenic obesity

Yaxian Yang; Chunyu Wang; Ruiyuan Xu; Wang Xuan; Xiaoai Chen

Medicine · 2026

* Correspondence: Wang Xuan, Department of Endocrinology, the 940th Hospital Joint Logistics Support Forces of PLA, Lanzhou, Gansu 730050, China (e-mail: wangxuan940xuan@163.com).Copyright © 2026 the Author(s). Published by Wolters Kluwer Health, LLC.2026https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Lanzhou Science and Technology Program Project2023‑ZD‑185Xuan Wang

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T21:45:24.861173+00:00

DOI: 10.1097/md.0000000000050799 · PMC13619247